People | January 19, 2022
Sauri Gudlavalleti is the new Chief Operating Officer of Sai Life Sciences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The company is one of the most profitable companies manufacturing speciality chemicals in India
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
